Who backs CytoAgents?
15 investors| Investor | Type |
|---|---|
| National Institutes of Health | Other |
| Innovation Works | Venture capital |
| Richard King Mellon Foundation | Other |
| AlphaLab Health | — |
| BlueTree Allied Angels | — |
| Boston Harbor Angels | — |
| Carl Nicolia | — |
| Delaware Crossing Investor Group | — |
| EQx Fund | — |
| Lehigh Valley Angel Investors | — |
| + 5 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
CytoAgents investors
15 investors are on record for CytoAgents, including National Institutes of Health, Innovation Works, Richard King Mellon Foundation and AlphaLab Health. The early-stage round in May 2023 drew 23 investors.
Free account
More of CytoAgents with a free account
- ·The complete investor list: 15 names
- ·Watch CytoAgents: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 15 firms already write checks for companies like CytoAgents. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View